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At Harvard today an invitation-only group of mostly scientists, lawyers, and entrepreneurs, 
~150 in total, met to discuss if and how to synthesize from scratch an entire human genome – 
the heritable genetic material that in nature is transferred from parents to children. The 
meeting was originally organized to focus on “deliverables and industry involvement” with 
the primary goal of the project being “to synthesize a complete human genome in a cell line 
within a period of ten years.”  
 
Synthesis refers to the construction of a genome starting from simple chemicals.  Such a 
synthetic genome could then be tested in a laboratory by replacing the existing genome 
within a human cell. All this would still be far removed from making a synthetic human.  
However, the possibility of making a human cell whose genome is realized from only digital 
information and raw materials should trigger broader considerations.    
 
For context, total synthesis of a human genome has become plausible at an accelerating 
rate. Thanks to new production techniques developed since 2003 the cost of assembling 
the genetic material encoding genes, the “building blocks” of life, has decreased from 
four dollars to just three cents per individual letter or “base pair” of deoxyribonucleic 
acid (DNA).  As a result, the estimated initial cost of printing the DNA fragments 
encoding a 3 billion base pair human genome has dropped from $12 billion to $90 
million.  If cost reductions continue apace this price would approach $100,000 within 20 
years. However, such dramatic additional cost reductions might never be realized without 
overwhelming demand. 
 
Advocates of synthesizing a human genome therefore argue that some open, collaborative 
“grand challenge” is needed to drive development of such technologies.  While we 
strongly agree that sustained improvements in DNA construction tools are essential for 
advancing basic biological science and improving public health we are skeptical that 
synthesizing a human genome is an appropriate demand driver. We recall how 
controversies associated with many of the earliest genome synthesis projects produced 
unintended consequences.  For example, a project that made polio virus from scratch in 
2002 led to cancelled public funding for DNA synthesis research, unwittingly hindering 
research across diverse and unrelated fields, as policy makers struggled to imagine how 
such a technology could ever be controlled. From a simple technical perspective, we 
argue that synthesis of less-controversial and more-immediately useful genomes and also 
greatly improved sub-genomic synthesis capacities (e.g., real-time plasmid printing) 
should be pursued; alternatives that would deliver broad and diverse benefits. 
 
Other topics on today’s agenda included changing the human genome itself.  For example, 
could scientists synthesize a modified human genome that is resistant to all natural 
viruses?  They likely could, for purely beneficial purposes, but what if others then sought 
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to synthesize modified viruses that overcame such resistance? Might doing so start a 
genome engineering arms race?  And, what of even greater changes that can be 
imagined? In a world where human reproduction has already become a competitive 
marketplace, with eggs, sperm and embryos carrying a price, it is straightforward to 
brainstorm various uses of human genome synthesis capacities.  For example, would it be 
OK to sequence and then synthesize Einstein’s genome?  If so how many Einstein 
genomes would it be OK to make and install in cells, and who would get to make and 
control these cells?  What if the project was a joint collaboration between Israel and Iran? 
 
Returning to our primary question, just because something becomes possible, how should 
we determine if it is ethical to proceed?  
 
Given that human genome synthesis is a technology that could be used to completely 
redefine the core of what now joins all of humanity together as a species, we argue that 
discussions of making such capacities real, like today’s Harvard conference, should not 
take place without open and advance consideration of whether and under what 
circumstances it is morally right to proceed. When the first actors at the table mostly have 
a significant material interest in proceeding, everyone, not just those in the room, risks 
out-of-control competition between public and private interests, ethical conflicts of 
interest, and temptations to manipulate human subject consent. Pluralistic, public, and 
deliberative discussions are instead the best appropriate way to frame paths forward. 
 
In closing, we note that the narrative of creation of the human is the central narrative for 
many religious communities. To create a human genome from scratch would be an 
enormous moral gesture whose consequences should not be framed initially on the advice 
of lawyers and regulators alone. The perspectives of others including self-identified 
theologians, philosophers, and ethicists from a variety of traditions should be sought out 
from the very beginning. Critical voices representing civil society, who have long been 
skeptical of synthetic biology’s claims, should also be included.  The creation of new 
human life is one of the last human-associated processes that has not yet been 
industrialized or fully commodified. It remains an act of faith, joy, and hope.  Discussions 
to synthesize, for the first time, a human genome should not occur in closed rooms.    
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